S100A8 and prostate carcinoma: Additionally, HIF-1 has been demonstrated to increase S100A8/A9 mRNA levels in prostate cancer epithelial cells by directly binding to the S100A8 and S100A9 promoters.129 S100A8/A9 can be either passively released due to cell death or the formation of NETs, or actively released through inflammation.